Ocugen, Inc. OCGN
- OCU200 — Diabetic Macular Edema Phase 1
- OCU200 — Diabetic Retinopathy Phase 1
- OCU200 — Wet Age-Related Macular Degeneration Phase 1
Home › Targets › integrin receptors
Companies with an active program directed at integrin receptors.